Trade AbbVie ^ABBV

87,345 AbbVie Inc. $ABBV Shares Purchased by Bank Julius Baer & Co. Ltd Zurich

Analysts Are Bullish on Top Healthcare Stocks: AbbVie (ABBV), Agios Pharma (AGIO)

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Thermo Fisher (TMO) and AbbVie (ABBV)

AbbVie price target raised to $319 from $305 at BofA

AbbVie price target raised to $346 from $310 at Morgan Stanley

AbbVie price target raised to $295 from $275 at UBS

AbbVie Earnings: Raising Our Fair Value Estimate With Significant Pipeline Progress | Morningstar

AbbVie's Solid Immunology Portfolio and Innovative Pipeline Support a Wide Moat | Morningstar

Promising Healthcare Stocks To Research - November 1st - Markets Daily

AbbVie Inc. $ABBV Stake Lowered by ProShare Advisors LLC - Markets Daily

25,704 AbbVie Inc. $ABBV Shares Bought by Vise Technologies Inc. - Markets Daily

AbbVie Inc. $ABBV Shares Sold by Sumitomo Mitsui Trust Group Inc.

Mirae Asset Global Investments Co. Ltd. Acquires 537,976 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Stake Trimmed by ProShare Advisors LLC

AbbVie Inc. $ABBV Stock Bought by Investment Partners LTD.

Summit Global Investments Purchases 5,220 Shares of AbbVie Inc. $ABBV

Marin Bay Wealth Advisors LLC Sells 5,723 Shares of AbbVie Inc. $ABBV

Partners Wealth Management LLC Buys 2,631 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Purchased by Vise Technologies Inc. - Stock Observer

AbbVie Inc. $ABBV Stock Position Boosted by Investment Partners LTD. - Stock Observer

Partners Wealth Management LLC Acquires New Position in AbbVie Inc. $ABBV - Stock Observer

AbbVie (ABBV) Q3 Earnings Lift Guidance As Debt Concerns Linger

Anika Therapeutics (NASDAQ:ANIK) versus AbbVie (NYSE:ABBV) Head to Head Comparison - Zolmax

Anika Therapeutics (NASDAQ:ANIK) and AbbVie (NYSE:ABBV) Financial Analysis - Daily Political

Biotech Stocks Worth Watching - October 31st - Markets Daily

Promising Pharmaceutical Stocks To Follow Today - October 31st - Stock Observer

AbbVie Inc. $ABBV Stock Sold by Greenup Street Wealth Management LLC - Markets Daily

AbbVie Inc. $ABBV Stock Sold by Greenup Street Wealth Management LLC - Zolmax

Modera Wealth Management LLC Purchases 7,590 Shares of AbbVie Inc. $ABBV

Raleigh Capital Management Inc. Sells 3,794 Shares of AbbVie Inc. $ABBV

Is Earnings Beat Altering The Investment Case For AbbVie Stock (ABBV)?

AbbVie Inc. $ABBV Stock Sold by VIRGINIA RETIREMENT SYSTEMS ET Al - Markets Daily

AbbVie (NYSE:ABBV) Hits New 12-Month High - Still a Buy? - Stock Observer

AbbVie Increases Profit Outlook Due to Surge in Immunology Drug Sales, ETPharma

Health Care Up on Defensive Rotation - Health Care Roundup | Morningstar

Q3 earnings round-up: AstraZeneca, AbbVie, Kenvue

AbbVie Scores Win in Fight Over Botox Selected for US Price Cuts

AbbVie (NYSE:ABBV) Releases Earnings Results, Beats Estimates By $0.09 EPS

AbbVie Stocks Rise 1.75% With Two Medicines Providing Nearly Half of Revenue

What AbbVie (ABBV) Said on Its Q3 Earnings Call

AbbVie (NYSE: ABBV) raises its profit outlook as immunology sales jump 16.3% - Stock Observer

AbbVie Lifts 2026 Outlook as Immunology, Neuroscience Quarterly Sales Beat Views

AbbVie Inc. (ABBV) Stock: Rise as Q3 Revenue Jumps 10.3% and EPS Tops $3.82

$250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends

CDs Offer Fixed Interest. AbbVie Offers a Growing Dividend. Which Should Retirees Choose?

Stock Market Today: Nasdaq Futures Plunge 2% as Big Tech Sells Off

Since HDV Switched to Monthly Pay, Here's What's Changed for Income Investors - 24/7 Wall St.

AbbVie (NYSE:ABBV) Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS - Daily Political

AbbVie beats estimates but stock dips

AbbVie Is Up 10% in a Month to a 52-Week High: Is There "More Room for Multiple Expansion"?

AbbVie Raises FY26 Adj. EPS Outlook; Boost Dividend 5.2% - Update

AbbVie 3Q Revenue Rises on Strength in Immunology, Neuroscience | Morningstar

AbbVie Q3 Income Advances

Soltis Investment Advisors LLC Acquires 12,825 Shares of AbbVie Inc. $ABBV

4,523 Shares in AbbVie Inc. $ABBV Acquired by Livelsberger Financial Advisory

AbbVie Inc. $ABBV Stake Lessened by Everett Harris & Co. CA

AbbVie Inc. $ABBV Stake Boosted by Choreo LLC

AbbVie Inc. $ABBV Stock Holdings Raised by China Universal Asset Management Co. Ltd.

AbbVie News | Markets Insider

AbbVie (ABBV) Stock Still Looks Cheap On Its 197% Five Year Run

Alphabet's Record Plunge Drags Down Tech as the Rest of the Market Rallies

0% Above Fair Value? AbbVie (ABBV) On Fresh Qulipta Phase 3 Data

AbbVie Stock: What 10 Years of Growth and Dividends Did for $1,000

AbbVie (NYSE:ABBV) Sets New 1-Year High - Here's What Happened

4 Reliable Dividend Stocks, Led by UPS, to Build Lifetime Passive Income

AbbVie's QULIPTA Outperforms Topiramate In Phase 3 Migraine Prevention Study

AbbVie Inc. $ABBV Shares Sold by LaFleur & Godfrey LLC

AbbVie TEMPLE Study Demonstrates Superior Tolerability and Efficacy of Atogepant (QULIPTA®) in Head-to-Head Migraine Prevention Trial

3,985 AbbVie Inc. $ABBV Shares Bought by Sowell Financial Services LLC

AbbVie Inc. $ABBV Shares Sold by BLB&B Advisors LLC

Follicular Lymphoma Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight | ABNewswire

AbbVie (ABBV) Seeks FDA Approval For Etentamig In Multiple Myeloma

AbbVie's BOTOX Cosmetic Day Returns November 18 With Special Offers

Why JEPI's Total Return Has Outpaced Its Payout

AbbVie Inc. $ABBV Stock Purchased by Sigma Investment Counselors Inc.

The Countdown Is On: BOTOX® Cosmetic (onabotulinumtoxinA) Day is Back Nov. 18 | Morningstar

Retire on Dividends: 5 High-Yield Stocks Boomers Are Buying and Holding Forever

What State Street Health Care SPDR (XLV) Bought: Eli Lilly Leads on Oct. 26

AbbVie (ABBV) Expected to Post Quarterly Earnings on Friday - Zolmax

AbbVie Inc. $ABBV Stock Holdings Lowered by Penobscot Investment Management Company Inc. - Stock Observer

Victory Financial Group LLC Buys 2,768 Shares of AbbVie Inc. $ABBV - Daily Political

Why AbbVie's next wave of blockbuster drugs has me buying the stock

Pharmaceutical Stocks To Research - October 27th - Zolmax

Biotech Stocks To Watch Now - October 27th - Markets Daily

AbbVie Inc. $ABBV Shares Newly Bought by Sunesis Advisors LLC - Zolmax

2,729 AbbVie Inc. $ABBV Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA - Markets Daily

AbbVie Submits FDA Application For Etentamig In Multiple Myeloma

Geneva Partners LLC Makes New $3.12 Million Investment in AbbVie Inc. $ABBV - Zolmax

Oppenheimer & Co. Inc. Buys 14,115 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Purchased by Verdence Capital Advisors LLC

Sunesis Advisors LLC Acquires 9,159 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Miller Howard Investments Inc. NY

Leo Wealth LLC Acquires New Shares in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Newly Bought by Geneva Partners LLC

10,800 AbbVie Inc. $ABBV Shares Sold by Hourglass Capital LLC - Markets Daily

Hourglass Capital LLC Sells 10,800 Shares of AbbVie Inc. $ABBV

Boeing Stock Forecast 2026–2030: Can a Record $745 Billion Backlog Reverse BA’s 11% Earnings Sell-Off?

Gold Price Forecast UAE 2026–2030: What Could 24K Gold Cost per Gram?

Pound to Rand Forecast: Can GBP/ZAR Break Above 22?

CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?

Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks

Best Stock CFD Broker in 2026: 9 Platforms Compared

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

Dow Advances on Value Rotation While Tech Sell-Off and Plunging Crude Drag S&P 500, Nasdaq Lower

Marvell to Acquire Lumentum in $115 Billion Deal as AI Connectivity Demand Grows

Gold Price Today: Bullion Holds Near $3,944 as Oil Retreat Eases Inflation Concerns

Oil Price Today: Brent Steadies Near $105 After 7.6% Plunge on US–Iran Talks

Oracle Stock Falls 8.85% as $20 Billion Funding Plan Revives AI Spending Concerns

Apple Stock Falls After Q4 Beat as Rising Memory Costs Weigh on Holiday Outlook

Oil Price Today Crashes 7.6% as Iran Peace Talks Ease Middle East Supply Fears

US Dollar Index Holds Near 102 Ahead of US Midterm Elections

Gold Price Today: Gold Reclaims $3,900 as Fed Rate Concerns Weigh on Recovery